Posted by Michael Wonder on 30 Nov 2015
Payer and policy maker steps to support value-based pricing for drugs
30 November 2015 - Prescription drugs is the only major category of health care services for which the producer is able to exercise relatively unrestrained pricing power.
For more details, go to: http://jama.jamanetwork.com/article.aspx?articleID=2474095&utm_source=Silverchair%20Information%20Systems&utm_medium=email&utm_campaign=JAMA%3AOnlineFirst11%2F30%2F2015
